All lobbying filings

SALT POINT STRATEGIES

SALT POINT STRATEGIES filed a Q4 report for THE RITEDOSE CORPORATION on January 18, 2026, reporting $90,000 in lobbying income.

Lobbying for THE RITEDOSE CORPORATION · Pharmaceutical CDMO and Generics Manufacturer.

All filings by SALT POINT STRATEGIES · Everything THE RITEDOSE CORPORATION has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 18, 2026

Income

$90,000

What the client paid this registrant for the period.

Client based in

South Carolina

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Trade (domestic/foreign)

Issues related to trade, tariffs, pandemic preparedness, domestic manufacturing.

Tariff (miscellaneous tariff bills)

Issues related to trade, tariffs, pandemic preparedness, domestic manufacturing.

Manufacturing

Issues related to trade, tariffs, pandemic preparedness, domestic manufacturing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.